Related Experiment Video
Updated: Jul 10, 2026

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
[Insomnia]
Damien Léger1, Pascale Ogrizek
1Centre du sommeil et de la vigilance, centre de référence hypersomnies rares, Hôtel-Dieu, Faculté de médecine Paris Descartes, 75181 Paris Cedex 04. damien.leger@htd.aphp.fr
Abstract:
Insomnia affects one adult on five, in France, and has severe consequences on daytime functioning. Using precise criteria, it is possible to differentiate insomnia from common sleep disorders. These criteria vary with age. Comorbid insomnia includes medical, psychological, circadian and toxic causes of insomnia which have to be eliminated to assess primary insomnia. In primary care a sleep focussed visit and a sleep log are helpful to confirm the diagnosis, appreciate the severity and evaluate the treatment. The treatment strategy is based on a step by step approach which has to be defined with the patient. The treatment is based on a combination of symptomatic hypnotics and psychological and behavioral treatments: stimulus control therapy, relaxation, sleep restriction, and cognitive-behavior therapies.
More Related Videos
Related Concept Videos
Insomnia
Multiple factors contribute...
Management of Insomnia
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
Sleep-Wake Cycles
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
Narcolepsy
Sleepwalking and Sleep Talking
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...

